Open Access

SGLT-2 inhibitors - Another piece of the puzzle in heart failure

Event: ESC Congress 2022
Topic: Heart Failure with Preserved Ejection Fraction (HFpEF)
Session type: Satellite Symposium
Organised by Radcliffe Medical Education - Supported by an unrestricted educational grant from AstraZeneca
Date: 29 August 2022
Time: 12:45 - 13:45

Congress Session

This content is currently on OPEN ACCESS

Sign in to view the resources

6 presentations in this session

SGLT2 inhibitors in HFpEF - Light at the end of the tunnel.

Speaker: Professor S. Solomon (Boston, US)
Thumbnail

SGLT2 inhibitors across the spectrum of heart failure.

Speaker: Professor J. McMurray (Glasgow, GB)
Thumbnail

Practical considerations for treating HF with mildly reduced and preserved EF.

Speaker: Professor C. Lam (Singapore, SG)
Thumbnail

Implementing best practices across the spectrum of heart failure.

Speaker: Doctor M. Vaduganathan (Boston, Massachusetts, US)
Thumbnail

4 speakers from this session

Professor Scott Solomon

Brigham And Women'S Hospital, Harvard Medical School, Boston (United States of America)
45 presentations
13 followers

Professor John J V McMurray

Western Infirmary, Glasgow (United Kingdom of Great Britain & Northern Ireland)
84 presentations
6 followers

Professor Carolyn Sp Lam

Duke-NUS Medical School, Singapore (Singapore)
105 presentations
22 followers

Doctor Muthiah Vaduganathan

Brigham and Women?s Hospital and Harvard Medical School, Boston, Massachusetts (United States of America)
4 presentations
0 follower

This platform is supported by

logo Novo Nordisk